The U.S. Food and DrugAdministration (FDA) is alerting health care professionals thatrepackaged intravitreal injections of Avastin (bevacizumab)have caused a cluster of serious eye infections in the Miamiarea.
The Florida Department ofHealth notified the FDA of a cluster of Streptococcusendophthalmitis infections in three clinics following intravitrealinjection of repackaged Avastin. Investigators traced thetainted injections to a single pharmacy located in Hollywood,Fla. The pharmacy repackaged the Avastin from sterileinjectable 100 mg/4 mL, single-use, preservative-free vials intoindividual 1 mL single-use syringes. The pharmacy thendistributed the Avastin to multiple eye clinics for use in treatingpatients.
To date, the FDA is aware of at least 12 patients in at leastthree of these clinics who had eye infections. While all of thesepatients had visual deficits prior to their injections withAvastin, some of these patients lost all remaining vision in thateye due to the endophthalmitis.
Continue Reading for Free
Register and gain access to:
- Breaking insurance news and analysis, on-site and via our newsletters and custom alerts
- Weekly Insurance Speak podcast featuring exclusive interviews with industry leaders
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the employee benefits and financial advisory markets on our other ALM sites, BenefitsPRO and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
